Skip to main content

Table 1 Sample characteristics

From: Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA

 

Gleason score at prostatectomy n (%)

Patients age (year)

Serum PSA level (ng/ml)

Pca (n = 24)

GS 6

8 (33.3%)

57.0 ± 7.0 (48.0–67.0)

4.2 ± 0.8 (2.7–5.1)

 

GS 7

GS(3 + 4)

5 (20.8%)

60.0 ± 10.0 (43.0–67.0)

4.7 ± 1.8 (2.8–6.8)

 

GS(4 + 3)

3 (12.5%)

62.0 ± 5.0 (62.0–66.0)

8.2 ± 28.1 (6.8–56.0)

 

GS 8

3 (12.5%)

67.0 ± 4.0 (60.0–68.0)

12.1 ± 3.0 (8.1–14.0)

 

GS 9

5 (20.8%)

63.0 ± 8.0 (59.0–79.0)

10.9 ± 9.2 (3.7–25.9)